Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences
- 26.09.2016
- brief report
Erschienen in:
- Verfasst von
- Prof. Dr. med. Sascha Meyer
- Prof. Dr. med. Ludwig Gortner
- NeoVitaA Trial investigators
- Erschienen in
- Wiener Medizinische Wochenschrift | Ausgabe 11-12/2017
Summary
The aim of the NeoVitaA Trial is to assess the role of postnatal additional high-dose oral vitamin A supplementation for 28 days in reducing Bronchopulmonary dysplasia (BPD) or death in extremely low birth weight (ELBW) infants at 36 weeks postmenstrual age (PMA). All infants (both intervention and control group) will be provided with basic vitamin A (1000 IU/kg/day) in addition to trial intervention.
In this short communication, we will give an up-date on obstacles, challenges as well as perspectives and potential solutions when putting into place a multicenter, double-blind, randomized trial in this cohort of extremely susceptible infants.
Anzeige
- Titel
- Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences
- Verfasst von
-
Prof. Dr. med. Sascha Meyer
Prof. Dr. med. Ludwig Gortner
NeoVitaA Trial investigators
- Publikationsdatum
- 26.09.2016
- Verlag
- Springer Vienna
- Erschienen in
-
Wiener Medizinische Wochenschrift / Ausgabe 11-12/2017
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X - DOI
- https://doi.org/10.1007/s10354-016-0500-z
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.